211 related articles for article (PubMed ID: 16449425)
1. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy.
Antoni MH; Carrico AW; Durán RE; Spitzer S; Penedo F; Ironson G; Fletcher MA; Klimas N; Schneiderman N
Psychosom Med; 2006; 68(1):143-51. PubMed ID: 16449425
[TBL] [Abstract][Full Text] [Related]
2. Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART.
Carrico AW; Antoni MH; Duran RE; Ironson G; Penedo F; Fletcher MA; Klimas N; Schneiderman N
Ann Behav Med; 2006 Apr; 31(2):155-64. PubMed ID: 16542130
[TBL] [Abstract][Full Text] [Related]
3. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men.
Antoni MH; Cruess S; Cruess DG; Kumar M; Lutgendorf S; Ironson G; Dettmer E; Williams J; Klimas N; Fletcher MA; Schneiderman N
Ann Behav Med; 2000; 22(1):29-37. PubMed ID: 10892526
[TBL] [Abstract][Full Text] [Related]
4. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men.
Lutgendorf SK; Antoni MH; Ironson G; Starr K; Costello N; Zuckerman M; Klimas N; Fletcher MA; Schneiderman N
Psychosom Med; 1998; 60(2):204-14. PubMed ID: 9560871
[TBL] [Abstract][Full Text] [Related]
5. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men.
Cruess S; Antoni M; Cruess D; Fletcher MA; Ironson G; Kumar M; Lutgendorf S; Hayes A; Klimas N; Schneiderman N
Psychosom Med; 2000; 62(6):828-37. PubMed ID: 11139003
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioural stress management with HIV-positive homosexual men: mechanisms of sustained reductions in depressive symptoms.
Carrico AW; Antoni MH; Weaver KE; Lechner SC; Schneiderman N
Chronic Illn; 2005 Sep; 1(3):207-15. PubMed ID: 17152183
[TBL] [Abstract][Full Text] [Related]
7. Cognitive behavioral stress management effects on mood, social support, and a marker of antiviral immunity are maintained up to 1 year in HIV-infected gay men.
Carrico AW; Antoni MH; Pereira DB; Fletcher MA; Klimas N; Lechner SC; Schneiderman N
Int J Behav Med; 2005; 12(4):218-26. PubMed ID: 16262540
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men.
Antoni MH; Cruess DG; Cruess S; Lutgendorf S; Kumar M; Ironson G; Klimas N; Fletcher MA; Schneiderman N
J Consult Clin Psychol; 2000 Feb; 68(1):31-45. PubMed ID: 10710838
[TBL] [Abstract][Full Text] [Related]
10. Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men.
Antoni MH; Cruess DG; Klimas N; Carrico AW; Maher K; Cruess S; Lechner SC; Kumar M; Lutgendorf S; Ironson G; Fletcher MA; Schneiderman N
J Psychosom Res; 2005 Jan; 58(1):3-13. PubMed ID: 15771864
[TBL] [Abstract][Full Text] [Related]
11. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial.
Parsons JT; Golub SA; Rosof E; Holder C
J Acquir Immune Defic Syndr; 2007 Dec; 46(4):443-50. PubMed ID: 18077833
[TBL] [Abstract][Full Text] [Related]
12. Effect of early highly active antiretroviral therapy on viral suppression among newly diagnosed men who have sex with men living with human immunodeficiency virus in Xi'an, China.
Wei X; Zhang Y; Santella AJ; Wang L; Zhuang G; Li S; Zhang H
J Med Virol; 2019 Jul; 91(7):1263-1271. PubMed ID: 30840771
[TBL] [Abstract][Full Text] [Related]
13. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
14. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men.
Cruess DG; Antoni MH; Schneiderman N; Ironson G; McCabe P; Fernandez JB; Cruess SE; Klimas N; Kumar M
Health Psychol; 2000 Jan; 19(1):12-20. PubMed ID: 10711583
[TBL] [Abstract][Full Text] [Related]
16. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons.
Berger S; Schad T; von Wyl V; Ehlert U; Zellweger C; Furrer H; Regli D; Vernazza P; Ledergerber B; Battegay M; Weber R; Gaab J
AIDS; 2008 Mar; 22(6):767-75. PubMed ID: 18356607
[TBL] [Abstract][Full Text] [Related]
17. Psychological distress and physical pain appear to have no short-term adverse impact on plasma HIV-1 RNA levels in patients on successful HAART.
Nettles RE; Keiffer TL; Cofrancesco J; Gallant JE; Quinn T; Jackson B; Flexner C; Carson KA; Wu AW; Siliciano RF
HIV Clin Trials; 2005; 6(5):262-71. PubMed ID: 16425464
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
